| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA5192667
Max Phase: Preclinical
Molecular Formula: C18H17N7O2S
Molecular Weight: 395.45
Associated Items:
Representations
Canonical SMILES: Cn1cc(C(=O)Nc2sc3c(c2C#N)CCN(C(=O)c2cnn(C)c2)C3)cn1
Standard InChI: InChI=1S/C18H17N7O2S/c1-23-8-11(6-20-23)16(26)22-17-14(5-19)13-3-4-25(10-15(13)28-17)18(27)12-7-21-24(2)9-12/h6-9H,3-4,10H2,1-2H3,(H,22,26)
Standard InChI Key: ZQBGISPLRBKTRO-UHFFFAOYSA-N
Associated Targets(Human)
143B 353 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 395.45 | Molecular Weight (Monoisotopic): 395.1164 | AlogP: 1.54 | #Rotatable Bonds: 3 |
| Polar Surface Area: 108.84 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 1 |
| #RO5 Violations: 0 | HBA (Lipinski): 9 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 12.95 | CX Basic pKa: 1.48 | CX LogP: 0.92 | CX LogD: 0.92 |
| Aromatic Rings: 3 | Heavy Atoms: 28 | QED Weighted: 0.72 | Np Likeness Score: -2.57 |
References
| 1. Jin W, Zhang T, Zhou W, He P, Sun Y, Hu S, Chen H, Ma X, Peng Y, Yi Z, Liu M, Chen Y.. (2022) Discovery of 2-Amino-3-cyanothiophene Derivatives as Potent STAT3 Inhibitors for the Treatment of Osteosarcoma Growth and Metastasis., 65 (9.0): [PMID:35476936] [10.1021/acs.jmedchem.2c00004] |
Source
Source(1):